Market Exclusive

Analyst Activity – Canaccord Genuity Reiterates Buy ➝ Positive on NASDAQ:IDXX – Idexx Laboratories (NASDAQ:IDXX)

Analyst Ratings For NASDAQ:IDXX – Idexx Laboratories (NASDAQ:IDXX)

Today, Canaccord Genuity reiterated its Buy ➝ Positive rating on NASDAQ:IDXX – Idexx Laboratories (NASDAQ:IDXX) with a price target of $215.00 ➝ $225.00.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:IDXX – Idexx Laboratories (NASDAQ:IDXX)
NASDAQ:IDXX – Idexx Laboratories (NASDAQ:IDXX) has insider ownership of 2.56% and institutional ownership of 86.97%.

Recent Trading Activity for NASDAQ:IDXX – Idexx Laboratories (NASDAQ:IDXX)
Shares of NASDAQ:IDXX – Idexx Laboratories closed the previous trading session at 213.80 up +1.60 0.75% with 213.1199951171875 shares trading hands.

Exit mobile version